Novartis Investigative Site

Curitiba

0 studies enrolling now · 5 studies all time

What they study most

Acute Heart Failure, Chronic Myeloid Leukemia, Parkinson's Disease, Systemic Juvenile Idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis With Active Flare

Studies at this site

• Global Non-interventional Heart Failure Disease Registry — Stopped early
• Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA) — Stopped early
• Flare Prevention Study of Canakinumab in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) — Completed
• A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy — Completed
• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE